Amgen (AMGN) stock news

Amgen third quarter sales rise 8%, led by cholesterol, cancer drugs

Amgen Inc. Appoints David W. Gibbs to Board of Directors, Effective October 26, 2026

On October 26, 2026, the Board of Directors of Amgen Inc. appointed David W. Gibbs as a director of the Company, effective immediately. Mr. Gibbs will serve as a member of the Board’s Audit Committee and its Compensation and Management…

ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data

At one of the year’s premiere meetings for cancer research, melanoma vaccine data hailed by scientists sparked a share sell-off on Wall Street, while a lung drug received a standing ovation.

Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

What Changed In Amgen's Story?

For questions about this article or underlying research, email help@trefis.com.

Amgen, Equifax among market cap stock movers on Tuesday

When Amgen's Forecast And Chart Say The Same Thing, Pay Attention

Amgen (AMGN) raised its revenue forecast for fiscal 2026 on August 4. Since the market close before that release, the stock has gained 15.2%, outpacing the 1.9% return of the S&P 500. A higher forecast or a climbing share price means…